Medtronic plc Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount
Medtronic plc (MDT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount of $50.00 million for the 12-month period ending 2024-04-26, per its 10-K filed 2026-06-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseAmortization · last filed 2026-06-18
- Medtronic plc effective income tax rate reconciliation, nondeductible expense, amortization, amount for the quarter ending 2021-04-30 was $15.00M.
- Medtronic plc effective income tax rate reconciliation, nondeductible expense, amortization, amount for the quarter ending 2021-01-29 was $12.00M.
- Medtronic plc effective income tax rate reconciliation, nondeductible expense, amortization, amount for the quarter ending 2020-10-30 was $16.00M.
- Medtronic plc effective income tax rate reconciliation, nondeductible expense, amortization, amount for the quarter ending 2020-07-31 was $7.00M.
- Medtronic plc effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2024 was $50.00M, a 78.57% increase from fiscal 2023.
- Medtronic plc effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2023 was $28.00M, a 40.43% decline from fiscal 2022.
- Medtronic plc effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2022 was $47.00M, a 6.00% decline from fiscal 2021.
- Medtronic plc effective income tax rate reconciliation, nondeductible expense, amortization, amount for fiscal 2021 was $50.00M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amortization, Amount 12 month |
|---|---|---|---|---|
| 2024-04-26 | $50.00M 10-K · filed 2026-06-18 | |||
| 2023-04-28 | $28.00M 10-K · filed 2025-06-20 | |||
| 2022-04-29 | $47.00M 10-K · filed 2024-06-20 | |||
| 2021-04-30 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | $27.00M derived: sum of 2 quarters · filed 2023-06-22 | $43.00M derived: sum of 3 quarters · filed 2023-06-22 | $50.00M 10-K · filed 2023-06-22 |
| 2021-01-29 | $12.00M 10-Q · filed 2021-03-05 | $28.00M derived: sum of 2 quarters · filed 2021-03-05 | $35.00M 10-Q · filed 2021-03-05 | |
| 2020-10-30 | $16.00M 10-Q · filed 2020-12-03 | $23.00M 10-Q · filed 2020-12-03 | ||
| 2020-07-31 | $7.00M 10-Q · filed 2020-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |